Female Urinary Incontinence and Pelvic Floor Dysfunction: A
Transcription
Female Urinary Incontinence and Pelvic Floor Dysfunction: A
Female Urinary Incontinence and Pelvic Floor Dysfunction: A Gynecologists’ perspective Hisham Khalil BSc, MD, FRCSC Urogynecology and Pelvic Reconstructive Surgery The Ottawa Hospital Assistant Professor, University of Ottawa Disclosures • Provided consulting services to Ethicon Inc Acknowledgements • Urology Nurses of Canada • AUGS (American Urogynecology Society) Agenda • What are pelvic floor disorders? – Epidemiology and definitions – Approach to the evaluation and treatment of stress urinary incontinence and pelvic organ prolapse – Case Presentations – Resource list Patient Presentation • 59 year old female with 3 prior vaginal deliveries • Seen in emergency department with urinary retention • Bilateral hydronephrosis • Pelvic and lower abdominal pain 4 What is the Pelvic Floor ? • The pelvic floor is a set of muscles, ligaments and connective tissue in the lowest part of the pelvis that provides support for a woman’s internal organs: • Bowel • Bladder • Uterus • Vagina and rectum What is the pelvic floor ? Barber MD. Contemporary views on female pelvic anatomy. Cleve Clin J Med 2005; Suppl 4: S3. • Level I: Uterosacral ligament complex • Level II: paravaginal attachments to the levatorani and arcustendineus fascia pelvis • Level III: perineal body, perineal membrane, superficial and deep perineal muscles Historic Paradigm What are Pelvic Floor disorders (PFD’s)? • Pelvic Organ Prolapse • Urinary Incontinence (stress, urge, mixed) • Voiding dysfunction (incomplete bladder emptying) • Defecatory disorders • Anal incontinence Pelvic Floor Disorders One in three women will experience a PFD in her lifetime Lawrence, JM, et al. Prevalence and Co-Occurrence of Pelvic Floor Disorders in Community-Dwelling Women. Obstetrics & Gynecology. 111(3). Nygaard I, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA, 300(11), Sept. 2008. Tahereh E., et al. The Frequency of Pelvic Floor Dysfunctions and their Risk Factors in Women aged 40‐55. Journal of Family and Reproductive Health 6(2), June 2012. Pelvic Floor Disorders • Age and life stage: – 1 in 3 women—risk increases with age. – Pregnancy and childbirth. – 1 in 4 younger women (20 to 39 years). • Lifestyle and behaviors: – Obesity and limited physical activity. – Smoking. Nygaard I, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA, 300(11), Sept. 2008. Tahereh E., et al. The Frequency of Pelvic Floor Dysfunctions and their Risk Factors in Women aged 40‐55. Journal of Family and Reproductive Health 6(2), June 2012. Urinary Incontinence in women Responsible for 10% of nursing home admissions $ 6 Billion US cost annually Morrison A, Levy R. Fraction of nursing home admissions attributable to urinary incontinence. Value Health. 2006 Jul-Aug;9(4):272-4. Health Care Utilization Minassian VA et al. The iceberg of health care utilization in women with urinary incontinence. In Urogynecol J. 2012: 23 ; 1087-1093. • 41% prevalence of urinary incontinence • 72% reported moderate to severe symptoms • 25% sought care, 23% received it • 12% received subspecialty care Definition of Stress Urinary Incontinence • ICS: Involuntary leakage of urine with effort or exertion or on sneezing or coughing • Due to either urethrovesical hypermobility or instrinsic sphincter deficiency (MUCP < 20 cm H2O ) Definitions • Urgency incontinence / OAB: – Involuntary urine lose immediately preceded by sudden compelling need to void – If urodynamic finding of involuntary contraction of detrusor muscle: detrusor overactivity – If neurological cause for detrusor dysfunction known: neurogenic detrusor overactivity – If unknown: idiopathic detrusor overactivity Distribution of Incontinence Types Epidemiology and Scope Ogah J, Cody JD, Rogerson L. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006375. DOI: 10.1002/14651858.CD006375.pub2. • Prevalence of SUI : 10-40% of community dwelling women • Annual incidence of 2-11% • Annual cost : $20 billion per year in the U.S. • 50%–75% of these costs attributable to routine care from incontinence pads, diapers, laundry, dry cleaning, odor control, bed pads, and skin care products EPINCOT Study Y.S. Hannestad et al. Journal of Clinical Epidemiology. 2000; 53: 1150–1157 Epidemiology and Scope Jonsson M, Levin P, Wu J. Obstetrics & Gynecology. 119(4):845-851, April 2012. Canada in Context “Canadians in Context - Aging Population: Human Resources and Skills Development Canada” http://www4.hrsdc.gc.ca/[email protected]?iid=33#foot_1 19 Urethral Sphincters Coordination between urethral sphincters and detrusor musculature Rahn DD et al. Obstet Gynecol Clin N Am. 2009; 36: 463–474 Vaginal delivery vs C/S ? Rortveit G et al. Urinary Incontinence after Vaginal Delivery or Cesarean Section (Norwegian EPINCONT Study) N Engl J Med 2003;348:900-7. Nulliparous C/S OR C/S Vs Nulliparity Vaginal Delivery OR Vag Delivery vs C/S Any incontinence 10.1 15.9 1.5 (1.2-1.9) 21.0 1.7 (1.3-2.1) Severe incontinence 3.7 6.2 1.4 (1.0-2.1) 8.7 2.2 (1.5-3.1) SUI 4.7 6.9 1.4 (1.0-2.1) 12.2 2.4 (1.7-3.2) Mixed UI 3.1 5.3 1.7 (1.2-2.5) 6.1 1.3 (0.9-1.9) Risk factors for SUI Stothers L, Friedman B. Risk factors for the development of stress urinary incontinence in women. Curr Urol Rep (2011) 12:363–369 • • • • • • • • • Age Hypoestrogenism Obesity (2x) Pregnancy Vaginal delivery Diabetes mellitus Pelvic surgery Genetic factors Others: Medications, smoking, high-impact exercise A 62 year old G3P3 presents to your office with a complaint of stress urinary incontinence, progressively worsening x 5 years. The Index Patient : Simplified Protocol Evaluation of SUI Farrell SA et al. The evaluation of stress incontinence prior to primary surgery. J Obstet Gynaecol Can 2003;25(4):313–8. • Complete history and physical examination • Cough test • Post-void residual volume • Urine Culture • Urinalysis • Bimanual Examination • Assessment of urethral mobility – Q-tip test > 30o General Inspection • Vulva: – Lichen sclerosis / lichen planus – Atrophy / lesions / cysts • Urethra: – Urethral caruncle – urethral mucosal prolapse – urethral diverticulum • Vagina: – Atrophy / estrogenization – Scarring / pain Value of the cough stress test McLennan M, Bent AE. Supine Empty Stress Test as a Predictor of Low Valsalva Leak Point Pressure. Neurourol Urodyn. 1998: 17; 121-127 • Cough test (provocative cough test) confirms presence of SUI. • Ideally, bladder filled with 300 cc or to a sense of fullness • Significant relationship between low leak point pressure and positive supine empty stress test (79% sensitivity, 62.5% specificity) • Negative Predictive value of 90% What about Urodynamic Testing ? Indications for Urodynamic Testing Farrell SA et al. SOGC Committee Opinion on Urodynamics Testing. J Obstet Gynaecol Can 2008;30(8):717–721 • No definitive criteria • 2008 SOGC Committee opinion (III-C): – when the diagnosis remains uncertain after an initial history and physical examination – when patient symptoms do not correlate with objective physical findings – if the patient fails to improve with treatment – in a clinical trial setting Randomized Trials of Urodynamics prior to Surgery for SUI Nager C et al. A randomized trial of urodynamic testing before stressincontinence surgery. NEJM. 2012 May 24;366(21):1987-97 • 630 women with demonstrable SUI randomized to undergo urodynamic testing or office evaluation only (n=315 each) • Successful treatment : – 76.9% in UDS group – 77.2% in evaluation only group QUID Questionnaire Farrell S, Bent A et al. Women’s ability to assess their urinary incontinence type using the QUID as an educational tool. Int Urogynecol J. 2013 : 24; 759-762. • Patients referred to urogynecology clinic for UI asked to complete QUID questionnaire • Physicians blinded to QUID results • n = 338 pts • High degree of agreement between patient self-assessment of UI type can physician assessment Urolog Information you get • Urinary frequency • Volumes voided • Incontinence episodes • Precipitating factors • Fluid intake Occult Stress Incontinence Haessler AL et al. Reevaluating occult incontinence.CurrOpinObstetGynecol 2005; 17: 535-40 • Urinary incontinence with valsalva maneuvers after reduction of prolapse [in the absence of detrusor contractions] • Patients with POP have distorted anatomy and risk factors for both POP and SUI • Severe uterovaginal prolapse can prevent urinary leakage and produce obstructive symptoms by elevating urethral resistance. • 11-22% of continent patients with POP > 3 stage will develop postoperative SUI after correction of apical or anterior prolapse • Source of much patient and clinician frustration Occult Stress Incontinence Haessler AL et al. Reevaluating occult incontinence.CurrOpinObstetGynecol 2005; 17: 535-40 • Methods to reduce prolapse: • Pessary • Rectal swabs • Gauze • Speculum blades • Poorly studied in the literature • Relationship between occult SUI and postoperative stress incontinence ? Relationship between OSUI and postoperative SUI ? Liang CC et al. Pessary Test to Predict Postoperative Urinary Incontinence in Women Undergoing Hysterectomy for Prolapse. Obstet Gynecol. 2004; 104(4): 795-800. • 79 patients evaluated for POP stage > 3 • 49 patients had + pessary test Vaginal hysterectomy, anterior and posterior repair and TVT Vaginal hysterectomy, anterior and posterior repair Objective Postoperative SUI : 0% Subjective Postoperative SUI: 10% Objective Postoperative SUI: 53 % Subjective Postoperative SUI: 64.7% Canadian Urological Association (CUA) Treatment Algorithm Corcos J, et al. http://www.cua.org/guidelines_e.asp : accessed Aug 29, 2013. Kegel Exercises Dumoulin C, Hay-Smith J. Pelvic Floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005654. • 14 trials (836 women) – 435 PFMT, 401 controls • Mean difference in number of SUI episodes per day -1.29 (95% CI -2.24, -0.34) • Mean difference in number of mixed UI episodes per day -0.77 (95% CI -1.22,-0.32) Simplified Kegel’s Protocol • Do two sets of exercises each day • Do 15 exercises for each set • Each exercise consists of two parts: – Part 1- Squeeze the pelvic muscles as strongly as you can and try to hold for a count of 5. Relax. – Part 2- Do 4 quick contractions one after the other. • Do a total of 30 exercises each day. • Each exercise session should take no more than 10 minutes. What is the value of Pelvic Floor Exercises ? Bo K, Nygaard I. Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years. Obstet Gynecol. 2005; 105: 999-1005 • 52 women with urodynamic stress urinary incontinence • 26 randomized to intensive pelvic floor physiotherapy • 26 randomized to home with instructions on Kegel exercises • 15 year follow-up with 90.4% response rate • 50% of patients in each group ultimately underwent surgery • 28% of patients continue to do pelvic floor exercises. Weighted vaginal cones Herbison GP, Dean N. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev. 2013 Feb 28;2:CD009407. • 23 trials involving 1806 women – 717 randomized to vaginal cones – Superior to no active treatment – Not superior to pelvic floor muscle retraining Incontinence Pessaries Robert M et a. J Obstet Gynaecol Can 2013;35(7 eSuppl):S1–S11 • Pessaries should be considered in all women presenting with urinary stress incontinence • Made of medical grade silicone • Incontinence pessaries elevate and slightly constrict the urethra. • If a woman develops stress incontinence after being fitted with a prolapse pessary, switching to an incontinence pessary may be beneficial. Current Incontinence Pessaries Ring with support and knob (SAK) Ring with knob Incontinence Pessaries Ring with support and knob (SAK) Uresta Pessary Pessaries ? Nager CW et al. Incontinence pessaries: size, POPQ measures, and successful fitting. Int Urogynecol J Pelvic Floor Dysfunct 2009;20(9):1023–8 • Initial successful fitting varies from 60-92% • At 1 year, overall continuation rates may be as low as 16% Farrell SA, et al. Continence pessaries in the management of urinary incontinence in women. J Obstet Gynaecol Can 2004;26(2):113–7 • 59% continence rate at 11 months • Reasons for discontinuing: persistent incontinence, pessary falling out, pain, bleeding Weight Loss ? Wing RR, et al. Improving Urinary Incontinence in Overweight and Obese women through modest weight loss. Obstet Gynecol. 2010; 116: 284-292. • 5-10% weight loss associated with significant improvments in frequency of UI Barriers to care ? Hagglund D et al. Reasons why women with long-term urinary incontinence do not seek professional help: a cross-sectional population-based cohort study. Int Urogynecol J. 2003: 14; 296-304. • Survey of 95 women aged 23-51 years with UI • Reasons for not seeking care: • Disorder is a minor problem • Coping on their own • Embarrassment • Reasons for seeking care: • afraid of the odor of urine • perceived the leakage as shameful and embarrassing. • Pelvic floor exercises were the most commonly used management methods for all participants. Female Pelvic Medicine and Reconstructive Surgery • Board Certification in U.S. since 2012 • 6 fellowship programs in Canada1 – 22 Canadians have completed these programs • 5 Canadian trainees moved to U.S. – 28 externally sponsored • Professional society guidelines recognize need for specialized training 1Cundiff G. On the Brink: The Future of Female Pelvic Medicine and Reconstructive Surgery in Canada. J Obstet Gynaecol Can. 2011; 33(12): 1253-1255 Subspecialty care ? 48 Stepwise continence Care Model Farrell S et al. Two models for delivery of women’s continence care: the step-wise continence team versus the traditional medical model. J Obstet Gynaecol Can 2009;31(3):247–253 • 154 patients in step-wise arm, and 78 in medical model arm. • Both groups showed significant improvement in all measures of urinary incontinence after treatment. • Step wise arm: education sessions and conservative therapies led by nurse continence advisor: – More rapid resolution of stress incontinence and irritative bladder symptoms. – Improved quality of life scores and treatment satisfaction. Nurse Continence Advisors Moore KH et al. Randomised controlled trial of nurse continence advisor therapy compared with standard urogynaecology regimen for conservative incontinence treatment: efficacy, costs and two year follow-up . BJOG. 2003; 110: 649-657. • 157 women with stress or urge incontinence undergoing conservative therapy with urogynecologist or NCA • No significant differences between groups in terms of pad tests, incontinence scores or quality of life scores • Longer duration of consultation with NCA • Labour costs lower • • • • Urologists, Urogynecologists Physiotherapists Nurses Family Physicians • Male and Female incontinence • Rationale: – Common Health Problems – Great impact on quality of life – Patients are not seeking help for their condition Trends in Management of SUI Jonsson F, et al. Obstet Gynecol. 2012 ; 119(4):845-851 Midurethral Slings Retropubic tape Trans-obturator tape Retropubic Midurethral Slings • Developed by Ulmsten and Petros in 1995 • “integral theory” of placing a sling distally • Based on theory that pubourethral ligaments support the midurethra and attach to pubis, acting as a “backboard” • Strip of polypropylene mesh to be left loose or “tension-less” to avoid direct compression of the urethra. Long-term cure ? 17 year data-TVT Nilsson et al. Seventeens years’ follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013. 24:1265-9. • 90% objective continence rate • 87% subjective cure rate Pelvic Organ Prolapse • Pelvic Organ Prolapse disorders affecting quality of life : 30% of the population (lifetime incidence of surgery 11.1%)1 • 45% increase in demand for treatments for Pelvic Floor disorders over next 30 yrs2 1Olsen, AL et al.ObstetGynecol 1997;89:501. et al. Am J Obstet Gynecol. 2001; 184(7): 1496-1503 2Luber KM, Surgical Management of POP Olsen, AL et al. Epidemiology of Surgically Managed Pelvic Organ Prolapse and Urinary Incontinence. Obstet Gynecol 1997;89:501. 29 % reoperation rate 44-54% anatomic failure Symptoms of Pelvic Organ Prolapse • Pelvic organ prolapse occurs with descent of one or more pelvic structures • Symptoms may affect a wide range of activities including sexual function, exercise, and have a detrimental impact on body image • Vaginal support defects occur with and without symptoms 1Lowder JL et al. Am J ObstetGynecol 2011; 204: 441.e1. ICS Definition of Pelvic Organ Prolapse An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. Neurourol Urodynam29:4–20 (2010) • Descent of one or more of the: – – – – anterior vaginal wall (central, paravaginal, or combination cystocele) posterior vaginal wall (rectocele) the uterus (cervix) the apex of the vagina (vaginal vault or cuff scar) after hysterectomy. • The presence of any such sign should correlate with relevant POP symptoms. • Diagnostic Criteria: symptoms and clinical examination, assisted by any relevant imaging Definitions • A definition of of clinically significant prolapse remains elusive. • ½ of parous women can be demonstrated to have prolapse by physical examination, most are asymptomatic. • Pelvic examination findings do not correlate well with specific pelvic symptoms. 1ACOG 2 Practice Bulletin No 85. ACOG 2007. Prolapse Definitions • Anterior compartment prolapse: cystocele • Apical compartment prolapse: uterine prolapse or vaginal vault prolapse Prolapse Definitions • Posterior compartment: hernia of posterior vaginal wall (rectocele) • Enterocele: hernia of the intestines through the vaginal wall. Terminology • Anterior prolapse vs cystocele ? • Posterior prolapse vs rectocele ? • Vaginal topography does not reliably predict location of the associated viscera. • Half of anterior prolapse can be attributed to apical descent Bump RC et al. Am J ObstetGynecol 1996; 175: 10. Summers A et al. Am J ObstetGynecol 2006; 194: 1438. What are the symptoms and clinical presentation of Pelvic Organ Prolapse ? Symptoms of Pelvic Organ Prolapse Bowel: -Incontinence of flatus or solid stool -incomplete emptying -straining during defecation -Urgency to defecate -Digital evacuation -Splinting to start or complete defecation -Feeling of blockage or obstruction during defecation Vaginal: -Sensation of bulge or protrusion -seeing or feeling bulge or protrusion -pressure -heaviness Urinary: -Incontinence -Frequency -Urgency -Weak or prolonged urinary stream -hesitancy -incomplete emptying -manual reduction of prolapse to start voiding -position change to start or complete voiding Sexual: -dyspareunia -abstaining from intercourse Take home: Severity of prolapse symptoms does not correlate well with stage of prolapse Splinting ? Jelovsek JE et al. Pelvic Organ Prolapse. Lancet. 2007; 369: 1027-1038. • Splinting: reporting of either a need to splint or push on or around the vagina to urinate, defecate or a feeling of a vaginal bulge • Suggests more advanced POP Does POP-Q stage correlate with symptoms ? Gutman RE et al. Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms ? Am J Obstet Gynecol. 2008; 199(6): 683.e1-7 • POP-Q > 2: noted among 37% of women presenting for annual gynecologic examinations. • The only symptom predicted by anatomic prolapse severity was bulging or protrusion symptoms (vaginal descent > 0.5 cm beyond the hymen). Tan JS et al. Predictive value of prolapse symptoms: a large database study. IntUrogynecol J Pelvic Floor Dysfunct 2005; 16: 203. • Vaginal bulge symptoms:sensitivity 67%, specificity 87%, for POP at or past the hymen What are risk factors for Pelvic Organ Prolapse ? History: Risk Factors for POP Hendrix SL et al. Pelvic Organ Prolapse in the Women’s Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002 ; 186(6): 1160-6 • n= 27,342women (16,616 had uterus) Risk Factors OR (95% CI) No Increased Risk Age 60-69 1.16 (1.03 – 1.30) Education Age 70-79 1.36 (1.19 – 1.56) Occupation Hispanic 1.24 (1.01 – 1.54) Hormone Therapy BMI 25-30 1.31 (1.15-1.48) Time since Menopause BMI> 30 1.40 (1.24-1.59) Breastfeeding Waist circumference> 88 cm 1.17 (1.06-1.29) Hysterectomy Parity 2.13 (1.67-2.72) Past Smoking Additional Parity> 1 1.10 (1.05-1.16) Coffee consumption Constipation 1.10 (1.03 – 1.16) EtOH Consumption Connective Tissue Disorders Carley ME et al. Urinary Incontinence and pelvic organ prolapse in women with Marfan or Ehlers Danlos Syndrome. Am J Obstet Gynecol. 200; 182(5): 1021-1023. • Marfan Syndrome: 33% prevalence POP • Ehlers Danlos Syndrome: 75% prevalence POP Hundley AF et a. Gene expression in the rectursabdominus muscle of patients with and without pelvic organ prolapse. Am J ObstetGynecol 2008; 198: 220e1-220e7 • Differential gene expression of MYH3 myosin related protein among patients with POP Symptoms of Pelvic Organ Prolapse: Take Home • Prolapse severity does not correlate well with symptoms • Vaginal topography does not correlate well with location of associated viscera • Asymptomatic women with pelvic organ prolapse do not require treatment • History may help clarify cases of severe prolapse – Splinting, bulge symptoms • Be alert to associated urinary and GI symptoms Physical Examination: What are the essential elements ? Physical Examination • Inspection • Bimanual examination – Pelvic masses • Assessment of pelvic organ prolapse – Location – Severity (grading) • • • • Rectovaginal examination Assessment of associated incontinence Neurological examination Supplementary testing ? Quantifying Pelvic Organ Prolapse: Baden Walker System • Grade 0 : No prolapse • Grade 1: Descent halfway to hymen • Grade 2: Descent to hymen • Grade 3: Descent halfway past hymen • Grade 4: Maximal possible descent for each site POP-Q Bump RC et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175:10-17 Treszezamsky AD et al. Female Pelvic Med Reconstr Surg. 2012 ; 18(1): 37-40. • 9 parameters • Useful in research studies or for post-surgical follow-up • Used by 59% of gynecologists in U.S. Kegel Strength Strength Grading / 5 0 No contraction 1 Contraction< 1 s 2 Weak contraction 1-3 s 3 Moderate contraction 4-6 s 4 Strong contraction 7-9 s repeated 3 times 5 Unmistakably strong Physical Examination • Sim’s speculum or lower blade of grave’s speculum retracting posterior vaginal wall Staging based on POP-Q • Stage 0: no prolapse demonstrated • Stage 1: most distal prolapse > 1 cm above the hymen • Stage 2: most distal portion of prolapse < 1 cm above or below hymen • Stage 3: most distal portion of prolapse > 1 cm below the hymen but no further than tvl – 2 cm • Stage 4: complete eversion of the total length of the lower genital tract U/S of upper urinary tract ? Hui SYA et al. A prospective study on the prevalence of hydronephrosis in women with pelvic organ prolapse and their outcomes after treatment. IntUrogynecol J. 2011; 22: 1529-1534 • Prospective evaluation of 233 patients with with stage 3 or 4 apical or anterior prolapse • Hydronephrosis in 10.3 %(95% CI 6-14%) • Resolved in 95% of patients after treatment • Value in setting of normal renal function uncertain Pelvic Floor U/S and MRI in patients with POP Tubaro A et al. Ultrasound Imaging of the Pelvic Floor: Where are we going ? NeurourolUrodynam. 2011; 30: 729-734. • Interesting correlations have been identified such as between childbirth, dimension of levator hiatus, avulsion of levatorani and risk of prolapse • Clinical benefit of pelvic floor imaging has yet to be demonstrated. Treatments • Symptom Based Approach: ─ POP is not life-threatening. ─ Treatments can help improve quality of life and sexual health. • Conservative approach: ─ Pelvic floor muscle exercises. ─ Pelvic floor physical therapy. • Pessary: ─ Support bladder, uterus and vagina. Food and Drug Administration. Information for Patients for POP, www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh. PFD Alliance. www.voicesforpfd.org. Introduction Surgery Obliterative -Colpocleisis Compensatory -Use of graft Bradley CS et al. Obstet, Gynecol. 2007; 109(4): 848-854 Reconstructive -Apex -Anterior -Posterior Goals of Surgery • Restore normal anatomy • No single operation is right for every patient • Desire to retain sexual function ? • Experience and training • Emerging controversies FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence Issued: October 20, 2008 • > 1000 reports of complications to 2008 – (9 manufacturers) • “FDA identified surgical mesh for transvaginal repair of POP as an area of continuing serious concern.” • Jan 2008 – Dec 2010: 2,874 additional reports of complications – 1,503 associated with POP repairs – 1,371 associated with SUI repairs http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm: accessed Jan 4th 2012 SGS Guidelines for use of Vaginal Grafts Murphy, M. Clinical Practice Guidelines on Vaginal Graft use from the Society of Gynecologic Surgeons. Obstet Gynecol 2008; 112: 1123. • Native tissue repair remains the default or standard of care • Nonabsorbable synthetic mesh: – may improve anatomic outcomes of anterior vaginal wall repair, but there are significant tradeoffs in regard to the risk of adverse events (3 studies included) Summary • POP is a common entity affecting QOL • Asymptomatic women do not require treatment • Diagnosis and decision making based on clinical exam and history • Role of ancillary testing is minimal in routine practice • Be alert to urinary incontinence / latent SUI Let’s Meet Some Patients… • 43 YO G2P2 healthy: – dairy farmer, smoker – procidentia & SUI – what are surgical options? 91 92 93 94 Take Home • Pelvic Floor disorders are common: – ask about them • Evaluation and treatment of pelvic floor disorders require a multi-disciplinary approach • Not a normal part of aging: can be treated successfully • Nurses and Nurse Continence Advisors constitute essential first line care Resources ─ ─ ─ ─ ─ www.voicesforpfd.org www.facebook.com/TaketheFloorPFD www.iuga.org/?patientinfo www.SOGC.org www.CUA.org